Novel mechanism for estrogen receptor alpha modulation of murine lupus.
Ontology highlight
ABSTRACT: Female sex is a risk factor for lupus. Sex hormones, sex chromosomes and hormone receptors are implicated in the pathogenic pathways in lupus. Estrogen receptor alpha (ER?) knockout (KO) mice are used for defining hormone receptor effects in lupus. Prior studies of ER? KO in lupus have conflicting results, likely due to sex hormone levels, different lupus strains and different ER? KO constructs. Our objective was to compare a complete KO of ER? vs. the original functional KO of ER? (expressing a short ER?) on disease expression and immune phenotype, while controlling sex hormone levels. We studied female lupus prone NZM2410 WT and ER? mutant mice. All mice (n = 44) were ovariectomized (OVX) for hormonal control. Groups of each genotype were estrogen (E2)-repleted after OVX. We found that OVXed NZM mice expressing the truncated ER? (ER? short) had significantly reduced nephritis and prolonged survival compared to both wildtype and the complete ER?KO (ER? null) mice, but surprisingly only if E2-repleted. ER? null mice were not protected regardless of E2 status. We observed significant differences in splenic B cells and dendritic cells and a decrease in cDC2 (CD11b+CD8-) dendritic cells, without a concomitant decrease in cDC1 (CD11b-CD8a+) cells comparing ER? short to ER? null or WT mice. Our data support a protective role for the ER? short protein. ER? short is similar to an endogenously expressed ER? variant (ER?46). Modulating its expression/activity represents a potential approach for treating female-predominant autoimmune diseases.
SUBMITTER: Cunningham MA
PROVIDER: S-EPMC6351212 | biostudies-literature | 2019 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA